Pfizer Unit, Teva Must Face Effexor Antitrust Litigation
Pfizer Inc. unit Wyeth and Teva Pharmaceuticals have fallen short in their bid to ax a proposed class action from end-payors alleging the companies engaged in a scheme to delay generic...To view the full article, register now.
Already a subscriber? Click here to view full article